Newly appointed NIH director Monica Bertagnolli expressed her concern about obesity and highlighted the importance of clinical trials in tackling this issue. She also outlined how participation in government-funded trials has remained static over the past decade while the ones associated with pharmaceutical companies have increased dramatically. Separately, FDA Commissioner Robert Califf reemphasized the need to address the falling life expectancy rates in the US, citing that the current expectancy for men is now at 73 years. He also mentioned that private insurers are responsible for ensuring that trials for accelerated approvals are completed.
To read more, click here.
[Source: Endpoints, November 14th, 2023]